United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2017_register
executive
2017-04-15
article
Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments
Notices
D09002ee1bdbdc2b8
D09002ee1bdbdc382
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Pharmacy Compounding Advisory Committee (PCAC). The general function of the committee is to provide advice on scientific, technical, and medical issues concerning drug compounding under the Federal Food, Drug, and Cosmetic Act (the FD&C Act), and, as required, any other product for which FDA has regulatory responsibility, and to make appropriate recommendations to the Agency. The meeting will be open to the public.
82 FR 18148
https://www.govinfo.gov/app/details/FR-2017-04-17/2017-07667
2017-07667
fr17ap17-62
4164-01-P
Docket No. FDA-2017-N-1847
https://www.govinfo.gov/app/details/FR-2017-04-17/2017-07667
https://www.govinfo.gov/content/pkg/FR-2017-04-17/html/2017-07667.htm
https://www.govinfo.gov/content/pkg/FR-2017-04-17/pdf/2017-07667.pdf
3 p.
18148
18150
82 FR 18148
Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments; Federal Register Vol. 82, Issue
NOTICE
2017-07667
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
2017-05-08
Docket No. FDA-2017-N-1847
4164-01-P
2017-07667
Notice; establishment of a public docket; request for comments.
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Pharmacy Compounding Advisory Committee (PCAC). The general function of the committee is to provide advice on scientific, technical, and medical issues concerning drug compounding under the Federal Food, Drug, and Cosmetic Act (the FD&C Act), and, as required, any other product for which FDA has regulatory responsibility, and to make appropriate recommendations to the Agency. The meeting will be open to the public.
The meeting will be held on May 8, 2017, from 8:30 a.m. to 4:30 p.m. and May 9, 2017, from 8:30 a.m. to 12 noon.
Cindy Hong, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301-796-9001, FAX: 301-847-8533, email: PCAC@fda.hhs.gov, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area). A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the Agency's Web site at http://www.fda.gov/ AdvisoryCommittees/default.htm and scroll down to the appropriate advisory committee meeting link, or call the advisory committee information line to learn about possible modifications before coming to the meeting.
Meetings:
Pharmacy Compounding Advisory Committee
,
PCAC@fda.hhs.gov
http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm
http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm408555.htm
http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm
http://www.fda.gov/AdvisoryCommittees/default.htm
https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf
https://www.regulations.gov
Federal Register
Vol. 82, no. 72
Office of the Federal Register, National Archives and Records Administration
2017-04-17
continuing
daily
deposited
born digital
144 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2017-04-17
P0b002ee19492643b
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr17ap17
https://www.govinfo.gov/app/details/FR-2017-04-17
https://www.govinfo.gov/content/pkg/FR-2017-04-17/pdf/FR-2017-04-17.pdf
https://www.govinfo.gov/content/pkg/FR-2017-04-17/xml/FR-2017-04-17.xml
fdlp
18079
18213
DGPO
2017-04-15
2023-04-28
FR-2017-04-17
machine generated
eng
FR
FR-2017-04-17
82
72